Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2025-12-25 @ 2:46 AM
NCT ID:
NCT06526533
Eligibility Criteria:
PLATFORM INCLUSION CRITERIA:
* Patients receiving ECMO
* Patients enrolled in the EXCEL Registry - NCT03793257
PLATFORM EXCLUSION CRITERIA:
* Treating clinician regards death as imminent and inevitable
* Treating clinician determines it is not in the patient's best interests
RBC TRANSFUSION DOMAIN INCLUSION CRITERIA:
• Aged 18 years or older
RBC TRANSFUSION DOMAIN EXCLUSION CRITERIA:
* Contraindication to RBC transfusion (including known patient preference)
* Limitations of care put in place either through patient wishes or the treating medical teams.
* Participant has already received ECMO \>12 hours. The start of ECMO is defined as the time of initiation of extracorporeal blood flow unless ECMO was initiated during a surgical intervention in which case the start of ECMO is defined as the arrival time into the initial ICU (post-surgery)
* The treating physician anticipates that ECMO treatment will cease before the end of tomorrow
* The treating physician deems the study is not in the patient's best interest
* The treating physician has concern regarding patient ability to tolerate restrictive or liberal transfusion trigger thresholds
* Actively listed for a solid organ transplant and has not yet received one
* Suspected or confirmed to be pregnant
* Previous ECMO treatment during the same hospital admission
Healthy Volunteers:
True
Sex:
ALL
Study:
NCT06526533
Study Brief:
Protocol Section:
NCT06526533